News
IconOVir Bio Announces Preclinical Proof-of-Concept Data for Proprietary Mutations Designed to Improve Selectivity of Novel Oncolytic Viruses, Including Lead Product Candidate ICVB-1042 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback